Immunotherapy and Coronavirus Disease 2019: Challenges and Possibilities

International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials

“…This affected the delivery of standard care for patients with lung cancer. 21,[23][24][25][26][27] Lung cancer patients had decreased utilization of outpatient services, hospital admissions, and surgical procedures during the first months of the pandemic. 27 A large allocation of health resources towards caring for patients sick with COVID-19 made it more difficult for many institutions to maintain standard care.…”

Primjena imunoterapije kod onkoloških bolesnika s bolešću COVID-19

“…Prvi slučaj nove bolesti, eng. corona virus disease 2019 (COVID- 19), u Hrvatskoj je potvrđen 25. veljače 2020. godine. Veliki izazovi postavljeni pred zdravstveni sustav i cjelokupnu zajednicu u biomedicinskim znanostima svakodnevno rezultiraju novim spoznajama o ma skupinama onkoloških bolesnika koje trebamo promatrati u doba COVID-19: prvu skupinu čine pacijenti u redovitom praćenju i oni koji su duže vrijeme bez onkološke terapije; drugu skupinu čine pacijenti u tijeku onkološkog liječenja za koje se grupno smatralo da djeluje imunosupresivno 6 .…”